Primarius Technologies (688206.SH) shareholders plan to reduce their holdings by no more than 2% in total.

16:08 20/09/2026

Primarius Technologies (688206.SH) announced that Jinqiu Investment, Jiacheng Investment, Jingyuan Investment, Ruicheng Investment, and Guoxing Tongying, due to their own funding needs, plan to reduce their holdings of the company's shares through centralized bidding in aggregate by no more than 5.3101 million shares, or no more than 1% of the company's total share capital, and through block trades in aggregate by no more than 5.3101 million shares, or no more than 1% of the company's total share capital, within 90 days after 15 trading days from the date of this reduction plan announcement. The above reduction plans together propose to reduce the company's shares by no more than 10.6203 million shares, or no more than 2% of the company's total share capital.

Primarius Technologies (688206.SH) announced that Jinqiu Investment, Jiacheng Investment, Jingyuan Investment, Ruicheng Investment, and Guoxing Tongying, due to their own funding needs, plan to collectively reduce their holdings of the company's shares through centralized bidding by no more than 5.3101 million shares, i.e., no more than 1% of the company's total share capital, within 90 days after 15 trading days from the date of this reduction plan announcement; and through block trades by no more than 5.3101 million shares, i.e., no more than 1% of the company's total share capital. The above reduction plans collectively propose to reduce no more than 10.6203 million shares of the company, not exceeding 2% of the company's total share capital.

ApicHope Pharmaceutical Group (300723.SZ) obtained the registration certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral Solution.

Shandong Xinhua Pharmaceutical (000756.SZ) obtained the drug registration certificate for Magnesium Sulfate, Sodium Sulfate, and Potassium Sulfate Oral Concentrated Solution.

Shandong Xinhua Pharmaceutical (000756.SZ) subsidiary obtains drug registration certificate for Donepezil Hydrochloride Orally Disintegrating Tablets.

ApicHope Pharmaceutical Group (300723.SZ) obtained the registration certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral Solution.

Shandong Xinhua Pharmaceutical (000756.SZ) obtained the drug registration certificate for Magnesium Sulfate, Sodium Sulfate, and Potassium Sulfate Oral Concentrated Solution.

Shandong Xinhua Pharmaceutical (000756.SZ) subsidiary obtains drug registration certificate for Donepezil Hydrochloride Orally Disintegrating Tablets.